Last 47 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -14.77 | 15.27 | 2.88 | — | 6.37 | — | — | — | 58.88 | 30.49 | 34.73 | 56.73 | 15.32 | 17.60 | 10.27 | 13.67 | 12.61 | 9.90 | 8.44 | 12.64 | 18.63 |
| — | — | — | — | -89.2% | — | — | — | +284.3% | +73.3% | +238.2% | +314.9% | +21.5% | +77.7% | +21.6% | +8.2% | -32.3% | -43.2% | -32.7% | -85.9% | -29.9% | |
| P/S Ratio | 0.52 | 0.48 | 0.13 | 0.20 | 0.30 | 0.30 | 0.34 | 0.31 | 0.59 | 0.66 | 0.73 | 0.87 | 0.96 | 1.08 | 0.77 | 0.99 | 1.02 | 0.86 | 0.79 | 1.08 | 1.57 |
| — | +58.4% | -61.7% | -34.5% | -50.0% | -54.4% | -53.3% | -64.3% | -38.3% | -38.9% | -5.0% | -12.0% | -6.7% | +25.9% | -3.5% | -8.0% | -34.8% | -36.6% | -20.4% | -16.5% | +24.4% | |
| P/B Ratio | 2.20 | 1.74 | 1.01 | 0.95 | 1.16 | 1.31 | 1.31 | 1.30 | 1.82 | 2.23 | 2.80 | 3.44 | 3.99 | 5.60 | 3.61 | 4.28 | 4.12 | 4.72 | 4.56 | 5.06 | 5.29 |
| — | +32.8% | -23.2% | -26.6% | -36.2% | -41.5% | -53.1% | -62.3% | -54.4% | -60.1% | -22.5% | -19.7% | -3.0% | +18.6% | -20.8% | -15.4% | -22.2% | -2.0% | +15.4% | +27.3% | +53.3% | |
| P/FCF | 6.08 | — | 0.32 | 2.26 | 12.69 | 2.89 | 2.83 | 4.04 | 8.55 | 6.78 | 9.44 | — | 5.74 | 6.27 | 33.23 | 12.32 | 13.07 | 5.95 | 6.60 | 23.30 | 1248.67 |
| — | — | -88.6% | -44.2% | +48.4% | -57.4% | -70.0% | — | +49.1% | +8.1% | -71.6% | — | -56.1% | +5.3% | +403.6% | -47.1% | -99.0% | -18.2% | -79.4% | -15.7% | +14429.9% | |
| EV / EBITDA | 11.54 | 7.27 | 1.53 | 7.60 | 8.22 | — | 9.16 | — | 10.59 | 9.54 | 10.81 | 13.50 | 8.25 | 10.31 | 6.72 | 8.37 | 7.87 | 6.56 | 5.93 | 8.36 | 11.79 |
| — | — | -83.3% | — | -22.4% | — | -15.3% | — | +28.4% | -7.5% | +61.0% | +61.3% | +4.8% | +57.1% | +13.3% | +0.1% | -33.2% | -40.0% | -31.6% | -57.9% | -6.6% | |
| EV / EBIT | 66.03 | 15.80 | 1.99 | 42.49 | 8.30 | — | 38.35 | — | 31.09 | 20.87 | 22.86 | 30.55 | 12.11 | 14.62 | 8.79 | 11.04 | 9.85 | 7.75 | 6.82 | 9.74 | 14.77 |
| — | — | -94.8% | — | -73.3% | — | +67.7% | — | +156.6% | +42.8% | +160.0% | +176.7% | +23.0% | +88.5% | +28.8% | +13.3% | -33.3% | -43.5% | -35.8% | -73.3% | -26.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.3% | 30.6% | 26.8% | 26.1% | 29.1% | 29.8% | 28.7% | 29.8% | 31.0% | 25.2% | 26.2% | 26.8% | 33.9% | 33.3% | 32.8% | 33.3% | 33.8% | 32.3% | 32.0% | 31.9% | 34.8% |
| — | +2.5% | -6.9% | -12.5% | -6.2% | +18.4% | +9.8% | +11.0% | -8.6% | -24.3% | -20.1% | -19.5% | +0.3% | +3.3% | +2.5% | +4.6% | -3.0% | -1.4% | -2.0% | -3.1% | +4.1% | |
| Operating Margin | 1.2% | 4.0% | 8.5% | 1.1% | 1.3% | -18.8% | 1.8% | -27.6% | 3.2% | 5.1% | 4.9% | 4.2% | 10.2% | 9.2% | 11.2% | 10.6% | 12.0% | 12.9% | 13.4% | 12.4% | 12.1% |
| — | +121.3% | +368.7% | +104.0% | -58.9% | -469.5% | -62.7% | -760.2% | -68.2% | -45.0% | -56.4% | -60.6% | -15.0% | -28.1% | -16.7% | -14.3% | -0.7% | +11.2% | +13.7% | +172.4% | +43.1% | |
| Net Margin | -3.5% | 3.1% | 4.5% | -1.0% | 4.6% | -17.7% | -0.2% | -25.5% | 1.0% | 2.2% | 2.1% | 1.5% | 6.2% | 6.1% | 7.5% | 7.3% | 8.1% | 8.7% | 9.4% | 8.5% | 8.4% |
| — | +117.8% | +2947.3% | +96.0% | +354.1% | -905.4% | -107.5% | -1772.3% | -83.7% | -64.3% | -71.7% | -79.0% | -23.3% | -29.2% | -20.6% | -14.8% | -3.7% | +11.4% | +18.4% | +478.3% | +78.5% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.2% | 2.9% | 9.2% | -1.2% | 4.7% | -17.6% | -0.2% | -23.5% | 0.8% | 1.9% | 2.1% | 1.5% | 6.7% | 7.1% | 8.4% | 7.5% | 8.5% | 11.7% | 13.0% | 10.5% | 7.4% |
| — | +116.6% | +6074.2% | +94.9% | +491.6% | -1036.6% | -107.5% | -1649.6% | -88.2% | -73.5% | -75.6% | -79.8% | -21.1% | -39.4% | -35.4% | -28.7% | +15.5% | +62.7% | +58.5% | +821.3% | +124.0% | |
| ROA | -4.2% | 0.9% | 2.6% | -0.4% | 1.3% | -5.0% | -0.0% | -7.4% | 0.3% | 0.6% | 0.6% | 0.4% | 2.0% | 2.2% | 2.9% | 2.8% | 3.1% | 4.0% | 4.6% | 4.0% | 2.8% |
| — | +116.9% | +5928.6% | +95.1% | +423.8% | -976.8% | -107.6% | -1748.0% | -87.2% | -73.9% | -79.5% | -83.8% | -34.6% | -44.3% | -36.3% | -30.4% | +10.7% | +56.3% | +62.5% | +904.4% | +150.4% | |
| ROIC | 1.6% | 1.9% | 7.5% | 0.4% | 0.4% | -5.8% | 0.5% | -7.9% | 0.8% | 1.4% | 1.4% | 1.3% | 3.6% | 3.7% | 5.0% | 4.9% | 5.6% | 7.5% | 8.5% | 7.0% | 4.5% |
| — | +133.6% | +1297.2% | +105.3% | -48.2% | -526.8% | -61.7% | -705.8% | -77.5% | -63.1% | -71.9% | -73.1% | -35.1% | -51.4% | -41.0% | -30.3% | +24.3% | +80.2% | +92.0% | +467.3% | +128.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.25 | 1.05 | 1.09 | 1.25 | 1.37 | 1.57 | 1.45 | 1.55 | 1.32 | 1.41 | 1.54 | 1.62 | 1.19 | 1.40 | 1.05 | 0.82 | 0.76 | 0.83 | 0.80 | 0.75 | 0.84 |
| — | -33.5% | -24.8% | -19.5% | +4.1% | +11.6% | -5.8% | -4.4% | +10.4% | +0.6% | +47.3% | +96.9% | +56.9% | +68.7% | +30.9% | +10.6% | -8.9% | -13.6% | -27.5% | -36.0% | -32.6% | |
| Debt / EBITDA | 4.23 | 13.26 | 5.08 | 17.70 | 18.41 | — | 19.80 | — | 17.98 | 14.99 | 15.58 | 17.47 | 7.65 | 8.26 | 6.07 | 5.47 | 5.05 | 3.98 | 3.61 | 4.41 | 6.57 |
| — | — | -74.3% | — | +2.4% | — | +27.1% | — | +135.1% | +81.5% | +156.4% | +219.1% | +51.4% | +107.5% | +68.4% | +24.0% | -23.1% | -46.6% | -53.1% | -75.6% | -51.5% | |
| Current Ratio | 0.94 | 1.13 | 1.09 | 0.94 | 1.05 | 1.00 | 1.08 | 1.09 | 1.18 | 1.23 | 1.27 | 1.28 | 1.18 | 1.20 | 1.33 | 1.27 | 1.35 | 1.24 | 1.29 | 1.39 | 1.40 |
| — | +13.3% | +1.0% | -13.4% | -10.9% | -18.9% | -15.0% | -15.0% | +0.5% | +2.5% | -4.9% | +0.6% | -13.2% | -3.6% | +3.4% | -8.4% | -3.5% | -8.3% | -7.0% | +10.3% | +5.5% | |
| Quick Ratio | 0.94 | 1.13 | 1.09 | 0.94 | 1.05 | 1.00 | 1.08 | 1.09 | 1.18 | 1.23 | 1.27 | 1.28 | 1.18 | 1.20 | 1.33 | 1.27 | 1.35 | 1.24 | 1.29 | 1.39 | 1.40 |
| — | +13.3% | +1.0% | -13.4% | -10.9% | -18.9% | -15.0% | -15.0% | +0.5% | +2.5% | -4.9% | +0.6% | -13.2% | -3.6% | +3.4% | -8.4% | -3.5% | -8.3% | -7.0% | +10.3% | +5.5% | |
| Interest Coverage | -1.22 | 3.84 | 17.46 | 0.66 | 4.95 | -10.89 | 1.01 | -8.76 | 1.54 | 2.40 | 2.40 | 1.69 | 7.53 | 7.53 | 12.25 | 10.13 | 15.22 | 18.21 | 21.68 | 17.21 | 20.26 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AMN stock.
AMN Healthcare Services, Inc.'s current P/E is -14.8x. The average P/E over the last 3 quarters is 8.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
AMN Healthcare Services, Inc.'s current operating margin is 1.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking AMN Healthcare Services, Inc.'s business trajectory between earnings reports.